MAY 20, 2017 10:37 AM PDT

Ebola's Comeback of 2017

WRITTEN BY: Xuan Pham

In January 2016, the World Health Organization (WHO) officially declared the end to the largest Ebola outbreak in history and everyone breathed a collective sigh of relief. But now, health officials are reporting a sudden increase in Ebola cases in a remote part of the Democratic Republic of Congo (DRC). Are we on the cusp of yet another Ebola crisis?

The first index case was reported on April 22, and involved a 45-year-old man who sought medical help for fever, vomiting, bleeding, and diarrhea. The man later died, as did the taxi driver and the aid who cared for the man at the hospital. So far, these deaths remain the only three attributed to the Ebola virus.

But the disease spreads quickly. The number of suspected Ebola cases is now up to 29; just less than a week ago the count was at 9. Officials are following over 400 people who may have come in contact with the virus.

The WHO classified the risk of Ebola spread as “high at the national level,” because the disease can spread quite rapidly in the remote part of the DRC, which has “suboptimal surveillance.” “Risk at the regional level is moderate due to the proximity of international borders and the recent influx of refugees from Central African Republic,” the organization said.

The Ebola virus causes severe hemorrhagic fevers, which can often be fatal. In fact, the virus kills up to 90 percent of people who catch it. The natural reservoir for Ebola is still unknown, but humans can get the virus through direct contact with infected blood or body fluids. People infected with Ebola start showing signs and symptoms from 2 to 21 days after exposure. In the beginning stages, symptoms can be non-specific, including fever, muscle pain, headache, and vomiting. Symptoms of hemorrhagic syndrome occur in the advanced stages of infection.

There are yet no licensed vaccines or therapies against this virus, but researchers have been busy testing out experimenntal therapies since the first outbreak began in 2014. One such unlicensed vaccine is manufactured by Merck, and is known as rVSVΔG-ZEBOV-GP. This drug was deployed in Guinea during the outbreak as part of the “ring vaccination” strategy, wherein all people who had contact with suspected Ebola cases were vaccinated.

Merk currently has a stash some 700,000 doses of the vaccine on ice. And some question why the drug has not been released to the DRC. In response, Marie-Paule Kieny, a WHO official who assisted with the Ebola epidemic in West Africa in 2014-16, said, “WHO is strongly in favor of using the vaccine in conjunction with the other interventions available. That said, the rVSV-ZEBOV Ebola vaccine is not yet available commercially, because it is still under review by the U.S. Food and Drug Administration and other regulatory agencies. In these circumstances the Ebola vaccine can only be used in a study protocol that includes ethical oversight and informed consent of individuals who agree to receive the vaccine.”

Additional sources: CNN, Science

Image credit: Wikipedia.org

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 04, 2019
Immunology
DEC 04, 2019
Predicting Death with Clinical Immune Indicators
Immune and inflammation status could help doctors predict which individuals are most at-risk for death. Results from a n ...
DEC 11, 2019
Clinical & Molecular DX
DEC 11, 2019
New 3-in-1 organ in a dish set to elevate research and diagnostics
In trying to understand complex phenomena in the human body, researchers usually have to turn to oversimplified biologic ...
JAN 14, 2020
Clinical & Molecular DX
JAN 14, 2020
Can I eat this donut? A quick test for celiac disease.
Genetic testing revealed that our ancestors have been eating wheat, rye, spelt and barley for over 8,000 years. Today, g ...
FEB 15, 2020
Clinical & Molecular DX
FEB 15, 2020
FDA nod for AI-powered technology to detect strokes
The US Food and Drug Administration (FDA) has provided clearance for a novel technology that uses artificial intelligenc ...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean ...
APR 07, 2020
Clinical & Molecular DX
APR 07, 2020
Computers Predict Diabetes with 94.9 Percent Accuracy
"Currently we do not have sufficient methods for predicting which generally healthy individuals will develop diabet ...
Loading Comments...